- Home
- KOD vs PK Comparison
KOD vs PK Comparison
Compare KOD & PK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KOD | PK |
|---|---|---|
| Founded | 2009 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.3B |
| IPO Year | 2018 | 2014 |
Fundamental Metrics
Financial Performance| Metric | KOD | PK |
|---|---|---|
| Price | $38.89 | $10.40 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 11 |
| Target Price | ★ $35.43 | $11.36 |
| AVG Volume (30 Days) | 1.6M | ★ 3.0M |
| Earning Date | 05-13-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 9.62% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $2,791,000,000.00 |
| Revenue This Year | N/A | $2.44 |
| Revenue Next Year | N/A | $2.49 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 2.35 |
| 52 Week Low | $1.92 | $8.27 |
| 52 Week High | $45.60 | $12.39 |
Technical Indicators
Market Signals| Indicator | KOD | PK |
|---|---|---|
| Relative Strength Index (RSI) | 64.44 | 42.41 |
| Support Level | $21.82 | $9.99 |
| Resistance Level | $45.60 | $10.96 |
| Average True Range (ATR) | 3.61 | 0.31 |
| MACD | 1.72 | 0.01 |
| Stochastic Oscillator | 73.03 | 29.41 |
Price Performance
Historical ComparisonAbout KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.
About PK Park Hotels & Resorts Inc.
Park Hotels & Resorts owns upper-upscale and luxury hotels, with 22,395 rooms across 36 hotels in the United States. Park also has interests through joint ventures in another 2,271 rooms in three US hotels. Park was spun out of Hilton Worldwide Holdings at the start of 2017, so most of its hotels are still under Hilton brands. The company has sold all its international hotels and many of its lower-quality US hotels to focus on high-quality assets in domestic gateway markets.